August Is SMA Awareness Month @checkrare
August Is SMA Awareness Month  @checkrare
Uploaded August 2026 | Updated November 2026, 5 hours ago
August is SMA Awareness Month, a time dedicated to increasing understanding of spinal muscular atrophy (SMA) and supporting the individuals and families impacted by this rare genetic neuromuscular condition. SMA affects the motor neurons, causing progressive muscle weakness and loss of movement. Most SMA types are caused by mutations in the SMN1 gene, while extra copies of the SMN2 gene modify the severity of disease. Early diagnosis and ongoing specialized care can make a significant difference in patient outcomes.

SMA has undergone a remarkable transformation over the past decade, with advances in disease-modifying therapies fundamentally improving muscle strength, patient mobility, and quality of life in persons living with this condition. However, many patients continue to face disease-related challenges that need to be recognized.

SMA Awareness Month is an opportunity to recognize the importance of continued research, multidisciplinary care, patient advocacy, and education within the rare disease community.

At CheckRare, we are committed to raising awareness of rare disorders like SMA and helping connect healthcare professionals and patients with timely educational resources, expert insights, and emerging clinical developments.

For insights on SMA from the Muscular Dystrophy Association (MDA) 2026 Clinical & Scientific Conference, visit checkrare.com/sma-in-focus-practical-insights-from-mda-2026

To learn more about the development of Itvisma gene therapy for SMA, visit checkrare.com/itvisma-gene-therapy-for-patients-with-spinal-muscular-atrophy

To learn about the changing definition of success in the care and management of SMA, visit checkrare.com/spinal-muscular-atrophy-the-changing-definition-of-success
August Is SMA Awareness MonthA Patient’s Journey With Essential Thrombocythemia and Polycythemia VeraRare Endocrine Exchange: Why This Conversation MattersNew Stem Cell Method Could Advance Research Into Spinal Muscular AtrophyImprovements in Mobility in Patients Treated with Miv-Cel with Stiff Person SyndromeUCB Study Highlights the Burden of Ocular Myasthenia GravisNarcolepsy Diagnosis and Symptoms: Understanding the Daily Burden of the DiseaseLiving With Ocular Symptoms of Myasthenia GravisNew Graves’ Disease Community WebsiteFDA Approves Multiple Myeloma Drug;  FDA Denies Neuroendocrine Drug; Safety Concerns For Prader-W...FDA CDER’s Accelerating Rare Disease Cures ProgramSeronegative Myasthenia Gravis Targeted Therapy Selection
CheckRare |

August Is SMA Awareness Month

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER